Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Funding will support world-leading cardiovascular disease research.

Patient in MRI scanner with heart scan image on screen

The British Heart Foundation has awarded the University of Oxford £5 million funding to support its world-class cardiovascular disease research over the next five years, the charity has announced today.

Researchers at the University welcomed the announcement. Professor Keith Channon, Head of the Radcliffe Department of Medicine and BHF Field Marshal Earl Alexander Chair of Cardiovascular Medicine at the University of Oxford, who led the bid for the award, said: 'The BHF Research Excellence Award underscores the scale, scope and quality of our research in heart and circulatory diseases. The new funding will support cross-disciplinary initiatives that will benefit patients by linking biological discovery science with data science and physical sciences, and will help to train the next generation of new research leaders'.

Professor Angela Russell, Professor of Medicinal Chemistry at the University of Oxford, who co-led the bid for the award, said: 'We are delighted to receive this new BHF Award which will allow us to build our connections with industry partners, and to pioneer a new entrepreneurship and innovation training programme to accelerate the development of future diagnostics and treatments for cardiovascular diseases'.

Read the full story on the Radcliffe Department of Medicine website.

Similar stories

Leading academics and innovators join refreshed BioEscalator Management Board

In its first major refresh since its establishment in 2018, the BioEscalator is delighted to welcome five leading University of Oxford academics and innovators to its Management Board. The Management Board provides a source of expertise for BioEscalator tenants and works to enhance research at the University by building strong links with small life sciences companies.